JP2024543455A5 - - Google Patents

Info

Publication number
JP2024543455A5
JP2024543455A5 JP2024527767A JP2024527767A JP2024543455A5 JP 2024543455 A5 JP2024543455 A5 JP 2024543455A5 JP 2024527767 A JP2024527767 A JP 2024527767A JP 2024527767 A JP2024527767 A JP 2024527767A JP 2024543455 A5 JP2024543455 A5 JP 2024543455A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
peptide contains
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024527767A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024543455A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/079681 external-priority patent/WO2023086913A2/en
Publication of JP2024543455A publication Critical patent/JP2024543455A/ja
Publication of JP2024543455A5 publication Critical patent/JP2024543455A5/ja
Pending legal-status Critical Current

Links

JP2024527767A 2021-11-11 2022-11-11 リラキシン-2融合タンパク質類似体及びそれを使用する方法 Pending JP2024543455A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163263917P 2021-11-11 2021-11-11
US63/263,917 2021-11-11
PCT/US2022/079681 WO2023086913A2 (en) 2021-11-11 2022-11-11 Relaxin-2 fusion protein analogs and methods of using same

Publications (2)

Publication Number Publication Date
JP2024543455A JP2024543455A (ja) 2024-11-21
JP2024543455A5 true JP2024543455A5 (cg-RX-API-DMAC7.html) 2025-11-19

Family

ID=86336636

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024527767A Pending JP2024543455A (ja) 2021-11-11 2022-11-11 リラキシン-2融合タンパク質類似体及びそれを使用する方法

Country Status (10)

Country Link
US (2) US12509497B2 (cg-RX-API-DMAC7.html)
EP (1) EP4429694A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024543455A (cg-RX-API-DMAC7.html)
KR (1) KR20240110824A (cg-RX-API-DMAC7.html)
CN (1) CN118510536A (cg-RX-API-DMAC7.html)
AU (1) AU2022388751A1 (cg-RX-API-DMAC7.html)
CA (1) CA3237801A1 (cg-RX-API-DMAC7.html)
IL (1) IL312731A (cg-RX-API-DMAC7.html)
MX (1) MX2024005654A (cg-RX-API-DMAC7.html)
WO (1) WO2023086913A2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023086913A2 (en) 2021-11-11 2023-05-19 Tectonic Therapeutic, Inc. Relaxin-2 fusion protein analogs and methods of using same
EP4713001A2 (en) 2023-05-18 2026-03-25 Tectonic Operating Company, Inc. Relaxin-2 fusion protein analogs and methods of using same

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4835251A (en) 1986-06-23 1989-05-30 Genetech, Inc. Method of chain combination
WO2007115414A1 (en) 2006-04-11 2007-10-18 University Of Guelph Modified h2 relaxin for tumor suppression
CA2704246A1 (en) 2007-10-30 2009-05-07 Howard Florey Institute Of Experimental Physiology And Medicine Chimeric relaxin polypeptides comprising an a and b chain derived from different relaxin family peptides
WO2010105081A1 (en) 2009-03-13 2010-09-16 Medtronic, Inc. Method of treating heart failure
US8389475B2 (en) 2009-08-10 2013-03-05 The Board Of Trustees Of The Leland Stanford Junior University Relaxin analogs
US20110245469A1 (en) 2010-04-02 2011-10-06 Athena Discovery, Inc. Intermediates formed in biosynthesis of relaxin-fusion proteins with extended in vivo half-lives
PE20140160A1 (es) 2010-08-17 2014-02-08 Ambrx Inc Polipeptidos de relaxina modificados y sus usos
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
WO2012031327A1 (en) 2010-09-08 2012-03-15 Howard Florey Institute Of Experimental Physiology And Medicine Modified relaxin polypeptides
GB201110833D0 (en) 2011-06-24 2011-08-10 Bold Venture Llc Compositions
AU2012280474A1 (en) 2011-07-01 2014-01-16 Bayer Intellectual Property Gmbh Relaxin fusion polypeptides and uses thereof
AU2012283235A1 (en) 2011-07-08 2014-01-09 Bayer Intellectual Property Gmbh Fusion proteins releasing Relaxin and uses thereof
AU2012291972B2 (en) 2011-08-04 2017-03-09 Pharis Biotec Gmbh Process for preparing human relaxin-2
EP2630964A1 (en) 2012-02-22 2013-08-28 Immundiagnostik AG Method and medicament for treating patients in risk of prediabetes and type-2 diabetes
WO2013177529A1 (en) 2012-05-24 2013-11-28 Angion Biomedica Corp. Relaxin-like compounds and uses thereof
US20160060322A1 (en) 2012-09-10 2016-03-03 Angion Biomedica Corp. Relaxin-like peptides and uses thereof
US9381231B2 (en) 2012-10-09 2016-07-05 University Of Florida Research Foundation, Inc. Use of relaxin to restore maternal physiology in pregnancies conceived by assisted reproductive technologies
US20150232526A1 (en) 2012-10-10 2015-08-20 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Use of relaxin to treat atrial fibrillation
US9005630B2 (en) 2012-11-01 2015-04-14 Veterinaerinstituttet Fusion proteins for the treatment of allergic diseases
US9907833B2 (en) 2013-07-25 2018-03-06 University Of Florida Research Foundation, Incorporated Use of relaxin to treat placental syndromes
WO2015038938A1 (en) 2013-09-13 2015-03-19 The California Institute For Biomedical Research Modified therapeutic agents and compositions thereof
JP6694381B2 (ja) 2013-09-24 2020-05-13 エラスタジェン・プロプライエタリー・リミテッドElastagen Pty Ltd タンパク質抽出方法
WO2015073727A1 (en) 2013-11-13 2015-05-21 Aequus Biopharma, Inc. Engineered glycoproteins and uses thereof
EP3083977B1 (en) * 2013-12-20 2018-02-28 F. Hoffmann-La Roche AG Improved recombinant polypeptide production methods
CA2945838C (en) 2014-04-17 2022-08-16 The Florey Institute Of Neuroscience And Mental Health Modified relaxin b chain peptides
EP2946788A1 (en) 2014-05-23 2015-11-25 Immundiagnostik AG Method and composition for treating heart failure with preserved ejection fraction
WO2016144968A1 (en) 2015-03-09 2016-09-15 University Of Washington Relaxin therapy for disorders of the diaphragm
GB201516068D0 (en) 2015-09-10 2015-10-28 Biomed Ltd B V Novel therapy
US11161891B2 (en) 2015-12-09 2021-11-02 The Scripps Research Institute Relaxin immunoglobulin fusion proteins and methods of use
CN115837014A (zh) 2016-05-18 2023-03-24 摩登纳特斯有限公司 编码松弛素的多核苷酸
US20190307811A1 (en) 2016-08-04 2019-10-10 Hudson Institute of Medical Research Method for treating airways disease
EP3522911B1 (en) 2016-10-07 2021-12-08 Beth Israel Deaconess Medical Center, Inc. Compositions comprising relaxin and methods of use thereof
WO2018138170A1 (en) * 2017-01-25 2018-08-02 Medimmune, Llc Relaxin fusion polypeptides and uses thereof
SG10201912034UA (en) 2017-02-08 2020-02-27 Bristol Myers Squibb Co Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
TW201934572A (zh) 2018-01-31 2019-09-01 法商賽諾菲公司 經修飾之鬆弛素b鏈胜肽及其治療用途
MY199821A (en) 2018-01-31 2023-11-23 Sanofi Sa Modified lipidated relaxin b chain peptides and their therapeutic use
WO2019149781A1 (en) 2018-01-31 2019-08-08 Sanofi Modified lipidated relaxin b chain peptides and their therapeutic use
TWI844709B (zh) 2019-07-31 2024-06-11 美商美國禮來大藥廠 鬆弛素(relaxin)類似物及其使用方法
EP4058048A1 (en) 2019-11-16 2022-09-21 Relaxera Pharmazeutische Gesellschaft mbH & Co. KG Medical composition for treating cardiac wasting and cachexia
JP2023524981A (ja) * 2020-05-08 2023-06-14 プレジデント アンド フェローズ オブ ハーバード カレッジ 操作されたリラキシンおよびその使用の方法
EP4153214A4 (en) 2020-05-22 2024-06-26 Trustees of Boston University Methods and compositions for treating a fibrotic disease
WO2021247475A1 (en) 2020-06-02 2021-12-09 Trustees Of Boston University Production of soluble relaxin and relaxin analogs
CR20230015A (es) 2020-06-17 2023-02-17 Medimmune Ltd Fusiones heterodiméricas de relaxina y usos de las mismas
CN114075276A (zh) 2020-08-17 2022-02-22 成都奥达生物科技有限公司 一种长效松弛素2类似物
CN113577289A (zh) 2021-01-11 2021-11-02 张莉 Rxfp1/3抑制剂在制备预防或治疗青少年特发性脊柱侧凸疾病的药物中的用途
WO2023028008A2 (en) 2021-08-23 2023-03-02 River 2 Renal Corp. Combination of relaxin and vasopressin analogues for treatment of renal disorders or conditions
EP4402474A1 (en) 2021-09-14 2024-07-24 Bellylabs OY Assay method for relaxin
US20250017867A1 (en) 2021-10-01 2025-01-16 Modernatx, Inc. Polynucleotides encoding relaxin for the treatment of fibrosis and/or cardiovascular disease
WO2023086913A2 (en) 2021-11-11 2023-05-19 Tectonic Therapeutic, Inc. Relaxin-2 fusion protein analogs and methods of using same
JP2024546877A (ja) 2021-12-15 2024-12-26 メドイミューン・リミテッド ヘテロ二量体リラキシン融合物を使用した治療
JP2025517100A (ja) 2022-05-07 2025-06-03 北京拓界生物医薬科技有限公司 リラキシン又は類似体の融合タンパク質及びその医薬的使用
JP2025528469A (ja) 2022-08-31 2025-08-28 リラクセラ ファルマツォイティッシュ ゲゼルシャフト エムベーハー ウント コー. カーゲー 免疫抑制薬及び処置方法
EP4713001A2 (en) * 2023-05-18 2026-03-25 Tectonic Operating Company, Inc. Relaxin-2 fusion protein analogs and methods of using same

Similar Documents

Publication Publication Date Title
JP2018171063A5 (cg-RX-API-DMAC7.html)
JP6545759B2 (ja) アゴニストおよびアンタゴニストとしての循環置換により修飾されるリガンド
CN103140236B (zh) 生长激素多肽及其制备和使用方法
JP2011501959A5 (cg-RX-API-DMAC7.html)
JP2020028308A5 (cg-RX-API-DMAC7.html)
US7112654B2 (en) Ligand for vascular endothelial growth factor receptor
RU2018117674A (ru) Композиции и способы для экспрессии нескольких биологически активных полипептидов с одного вектора для лечения заболеваний сердца и других патологий
WO2008051505A2 (en) Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
JP2023524981A5 (cg-RX-API-DMAC7.html)
JP2010536356A5 (cg-RX-API-DMAC7.html)
JP2023516653A5 (cg-RX-API-DMAC7.html)
WO2021083301A1 (zh) 多肽的生产和纯化方法
JP2023548945A5 (cg-RX-API-DMAC7.html)
CN101240033A (zh) 一种促胰岛素分泌肽与人血清白蛋白的融合蛋白及其制备方法
US12565516B2 (en) Carrier protein for improving properties of bioactive protein
US8008257B2 (en) ANF fusion proteins
CA2435466C (en) Use of il-18 inhibitors for the treatment and/or prevention of heart disease
CA3180251A1 (en) Cytokine conjugates
CN105524147A (zh) 重组聚多肽及其应用
JP7544599B2 (ja) ペプチドの血中動態改善方法
CN105085659B (zh) 一种重组利钠肽及其制备方法
CN113396163B (zh) 一种融合蛋白及其制法和用途
JP2004527253A (ja) 線維芽細胞成長因子−23分子およびその使用
CN103601808B (zh) 钠肽、制备方法及其在制备基因工程药物中的应用
JPH04159299A (ja) ヘパリン結合成長因子